Botulinum toxin type B: an open-label, dose-escalation, safety and preliminary efficacy study in cervical dystonia patients.
Cullis
P A
PA
Department of Neurology, Wayne State University School of Medicine, Detroit, Michigan 48093, USA.
O'Brien
C F
CF
Truong
D D
DD
Koller
M
M
Villegas
T P
TP
Wallace
J D
JD
D000328:Adult; D000368:Aged; D001905:Botulinum Toxins / Q000008:administration & dosage* / Q000009:adverse effects; D019274:Botulinum Toxins, Type A; D003714:Denervation; D004421:Dystonia / Q000150:complications / Q000188:drug therapy*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009334:Neck Muscles / Q000294:innervation / Q000503:physiopathology; D012720:Severity of Illness Index; D014103:Torticollis / Q000188:drug therapy* / Q000209:etiology
C096323:rimabotulinumtoxinB; D001905:Botulinum Toxins; D019274:Botulinum Toxins, Type A